Cardiovascular disease and the role of oral bacteria

Journal of Oral Microbiology

Volumn 2, Issue 2010, 2010, Pages

  Leishman, Shaneen J ^a   Do, Hong Lien ^a   Ford, Pauline J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cardiovascular disease; Cross reactivity; Heat shock proteins; Oral bacteria; Systemic inflammation

Indexed keywords

EID: 79953144925     PISSN: None     EISSN: 20002297     Source Type: Journal    
DOI: 10.3402/jom.v2i0.5781     Document Type: Article

References (183)

1. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138: s419-20.
2. Begg S, Khor SL, Bright ML, Stanley L, O'Brien J, Harper C. Overview of the burden of disease and injury in Queensland, 2003. Queensland burden of disease and injury circular series 1, no 1. Brisbane: Queensland health; 2008.
3. Heart, Stroke, and Vascular Diseases - Australian Facts 2004. Canberra: Australian Institute of Health andWelfare, National Heart Foundation of Australia, National Stroke Foundation Australia; 2004.
4. Crouse JR. Progress in coronary artery disease risk factor research: what remains to be done? Clin Chem 1984; 30: 1125-7.
5. Consensus report for periodontal diseases: pathogenesis and microbiol factors. Ann Periodontol 1996; 1: 926-32.
6. Papapanou PN. Periodontal diseases: epidemiology. Ann Periodontol 1996; 1: 1-36.
7. Mattila KJ, Valle MS, Nieminen MS, Valtonen VV, Hietaniemi KL. Dental infections and coronary atherosclerosis. Atherosclerosis 1993; 103: 205-11.
8. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. BMJ 1993; 306: 688-91.
9. Valtonen VV. Role of infections in atherosclerosis. Am Heart J 1999; 138: 431-3.
10. Beck JD, Elter JR, Heiss G, Couper D, Mauriello SM, Offenbacher S. Relationship of periodontal disease to carotid artery intima-media wall thickness: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol 2001; 21: 1816-22.
11. Gotsman I, Lotan C, Soskolne WA, Rassovsky S, Pugatsch T, Lapidus L, et al. Periodontal destruction is associated with coronary artery disease and periodontal infection with acute coronary syndrome. J Periodontol 2007; 78: 849-58.
12. Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR Jr, Sacco RL, et al. Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 2005; 111: 576-82.
13. Joshipura KJ, Rimm CW, Douglass D. Poor oral health and coronary heart disease. J Dent Res 1996; 75: 1631-6.
14. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Periodontal disease and cardiovascular disease. JAMA 2000; 284: 1406-10.
15. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Preexisting cardiovascular disease and periodontitis: a follow up study. J Dent Res 2002; 81: 186-91.
16. Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 2007; 154: 830-7.
17. Mustapha IZ, Debrey S, Oladubu M, Ugarte R. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and metaanalysis. J Periodontol 2007; 78: 2289-302.
18. Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med 2008; 23: 2079-86.
19. Li L, Messas E, Batista EL Jr, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein Edeficient murine model. Circulation 2002; 105: 861-7.
20. Lalla E, Lamster IB, Hofmann MA, Bucciarelli L, Jerud AP, Tucker S, et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003; 23: 1405-11.
21. Ford PJ, Gemmell E, Timms P, Chan A, Preston FM, Seymour GJ. Anti-P. gingivalis response correlates with atherosclerosis. J Dent Res 2007; 86: 35-40.
22. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998; 25: 134-44.
23. Rosan B, Lamont RJ. Dental plaque formation. Microbes Infect 2000; 2: 1599-607.
24. Lamont RJ, Jenkinson HF. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev 1998; 62: 1244-63.
25. Gemmell E, Seymour GJ. Immunoregulatory control of Th1/ Th2 cytokine profiles in periodontal disease. Periodontol 2000 2004; 35: 21-41.
26. Cullinan MP, Hamlet SM, Westerman B, Palmer JE, Faddy MJ, Seymour GJ. Acquisition and loss of Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans and Prevotella otella intermedia over a 5-year period: effect of a triclosan/ copolymer dentifrice. J Clin Periodontol 2003; 30: 532-41.
27. Lamont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, Weinberg A. Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun 1995; 63: 3878-85.
28. Gemmell E, Yamazaki K, Seymour GJ. Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit Rev Oral Biol Med 2002; 13: 17-34.
29. Gemmell E, Carter CL, Hart DN, Drysdale KE, Seymour GJ. Antigen-presenting cells in human periodontal disease tissues. Oral Microbiol Immunol 2002; 17: 388-93.
30. Gemmell E, Sernia C, Grieco DA, Bird PS, Allen CJ, Seymour GJ. Genetic variation in the recognition of Porphyromonas gingivalis antigens in mice. Oral Microbiol Immunol 2001; 16: 129-35.
31. Gemmell E, Bird PS, Carter CL, Drysdale KE, Seymour GJ. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model. Clin Exp Immunol 2002; 128: 238-44.
32. Milward MR, Chapple IL, Wright HJ, Millard JL, Matthews JB, Cooper PR. Differential activation of NF-kappaB and gene expression in oral epithelial cells by periodontal pathogens. Clin Exp Immunol 2007; 148: 307-24.
33. Bodet C, Chandad F, Grenier D. Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. Microbes Infect 2006; 8: 27-35.
34. Ji S, Kim Y, Min BM, Han SH, Choi Y. Innate immune responses of gingival epithelial cells to nonperiodontopathic and periodontopathic bacteria. J Periodontal Res 2007; 42: 503-10.
35. Grenier D. Nutritional interactions between two suspected periodontopathogens, Treponema denticola and Porphyromonas gingivalis. Infect Immun 1992; 60: 482-90.
36. Yao ES, Lamont RJ, Leu SP, Weinberg A. Interbacterial binding among strains of pathogenic and commensal oral bacterial species. Oral Microbiol Immunol 1996; 11: 35-41.
37. Saito A, Inagaki S, Kimizuka R, Okuda K, Hosaka Y, Nakagawa T, et al. Fusobacterium nucleatum enhances invasion of human gingival epithelial and aortic endothelial cells by Porphyromonas gingivalis. FEMS Immunol Med Microbiol 2008; 54: 349-55.
38. Metzger Z, Blasbalg J, Dotan M, Weiss EI. Enhanced attachment of Porphyromonas gingivalis to human fibroblasts mediated by Fusobacterium nucleatum. J Endod 2009; 35: 82-5.
39. Kesavalu L, Holt SC, Ebersole JL. Virulence of a polymicrobic complex, Treponema denticola and Porphyromonas gingivalis, in a murine model. Oral Microbiol Immunol 1998; 13: 373-7.
40. Yoneda M, Hirofuji T, Anan H, Matsumoto A, Hamachi T, Nakayama K, et al. Mixed infection of Porphyromonas gingivalis and Bacteroides forsythus in a murine abscess model: involvement of gingipains in a synergistic effect. J Periodontal Res 2001; 36: 237-43.
41. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1-14.
42. Netea MG, van Deuren M, Kullberg BJ, Cavaillon JM, Van der Meer JW. Does the shape of lipid A determine the interaction of LPS with toll-like receptors? Trends Immunol 2002; 23: 135-9.
43. Hayashi J, Masaka T, Ishikawa I. Increased levels of soluble CD14 in sera of periodontitis patients. Infect Immun 1999; 67: 417-20.
44. Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, Salomaa V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol 2007; 27: 1433-9.
45. Bascones-Martinez A, Munoz-Corcuera M, Noronha S, Mota P, Bascones-Ilundain C, Campo-Trapero J. Host defence mechanisms against bacterial aggression in periodontal disease: basic mechanisms. Med Oral Patol Oral Cir Bucal 2009; 14: e680-5.
46. Dixon DR, Bainbridge BW, Darveau RP. Modulation of the innate immune response within the periodontium. Periodontol 2000 2004; 35: 53-74.
47. Kinney JS, Ramseier CA, Giannobile WV. Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann NY Acad Sci 2007; 1098: 230-51.
48. Genco RJ. Host responses in periodontal diseases: current concepts. J Periodontol 1992; 63: 338-55.
49. Ebersole JL. Humoral immune responses in gingival crevice fluid: local and systemic implications. Periodontol 2000 2003; 31: 135-66.
50. Schifferle RE, Wilson ME, Levine MJ, Genco RJ. Activation of serum complement by polysaccharide-containing antigens of Porphyromonas gingivalis. J Periodontal Res 1993; 28: 248-54.
51. Imamura T. The role of gingipains in the pathogenesis of periodontal disease. J Periodontol 2003; 74: 111-8.
52. Potempa J, Sroka A, Imamura T, Travis J. Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes. Curr Protein Pept Sci 2003; 4: 397-407.
53. Abe N, Kadowaki T, Okamoto K, Nakayama K, Ohishi M, Yamamoto K. Biochemical and functional properties of lysinespecific cysteine proteinase (Lys-gingipain) as a virulence factor of Porphyromonas gingivalis in periodontal disease. J Biochem 1998; 123: 305-12.
54. Lantz MS, Allen RD, Duck LW, Blume JL, Switalski LM, Hook M. Identification of Porphyromonas gingivalis components that mediate its interactions with fibronectin. J Bacteriol 1991; 173: 4263-70.
55. Pike RN, Potempa J, McGraw W, Coetzer TH, Travis J. Characterization of the binding activities of proteinase-adhesion complexes from Porphyromonas gingivalis. J Bacteriol 1996; 178: 2876-82.
56. Nakayama K, Kadowaki T, Okamoto K, Yamamoto K. Construction and characterization of arginine-specific cysteine proteinase (Arg-gingipain)-deficient mutants of Porphyromonas gingivalis. Evidence for significant contribution of Arggingipain to virulence. J Biol Chem 1995; 270: 23619-26.
57. Calkins CC, Platt K, Potempa J, Travis J. Inactivation of tumor necrosis factor-alpha by proteinases (gingipains) from the periodontal pathogen, Porphyromonas gingivalis. Implications of immune evasion. J Biol Chem 1998; 273: 6611-4.
58. Banbula A, Bugno M, Kuster A, Heinrich PC, Travis J, Potempa J. Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Biochem Biophys Res Commun 1999; 261: 598-602.
59. Kadowaki T, Nakayama K, Yoshimura F, Okamoto K, Abe N, Yamamoto K. Arg-gingipain acts as a major processing enzyme for various cell surface proteins in Porphyromonas gingivalis. J Biol Chem 1998; 273: 29072-6.
60. Oleksy A, Banbula A, Bugno M, Travis J, Potempa J. Proteolysis of interleukin-6 receptor (IL-6R) by Porphyromonas gingivalis cysteine proteinases (gingipains) inhibits interleukin-6-mediated cell activation. Microb Pathog 2002; 32: 173-81.
61. Imamura T, Pike RN, Potempa J, Travis J. Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J Clin Invest 1994; 94: 361-7.
62. Imamura T, Potempa J, Tanase S, Travis J. Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. J Biol Chem 1997; 272: 16062-7.
63. Wingrove JA, DiScipio RG, Chen Z, Potempa J, Travis J, Hugli TE. Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (bacteroides) gingivalis. J Biol Chem 1992; 267: 18902-7.
64. Ransjo M, Marklund M, Persson M, Lerner UH. Synergistic interactions of bradykinin, thrombin, interleukin 1 and tumor necrosis factor on prostanoid biosynthesis in human periodontal-ligament cells. Arch Oral Biol 1998; 43: 253-60.
65. Rahman S, Bunning RA, Dobson PR, Evans DB, Chapman K, Jones TH, et al. Bradykinin stimulates the production of prostaglandin E2 and interleukin-6 in human osteoblast-like cells. Biochim Biophys Acta 1992; 1135: 97-102.
66. Sugawara S, Nemoto E, Tada H, Miyake K, Imamura T, Takada H. Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness. J Immunol 2000; 165: 411-8.
67. Duncan L, Yoshioka M, Chandad F, Grenier D. Loss of lipopolysaccharide receptor CD14 from the surface of human macrophage-like cells mediated by Porphyromonas gingivalis outer membrane vesicles. Microb Pathog 2004; 36: 319-25.
68. Tokuda M, Duncan M, Cho MI, Kuramitsu HK. Role of Porphyromonas gingivalis protease activity in colonization of oral surfaces. Infect Immun 1996; 64: 4067-73.
69. Tokuda M, Karunakaran T, Duncan M, Hamada N, Kuramitsu H. Role of Arg-gingipain A in virulence of Porphyromonas gingivalis. Infect Immun 1998; 66: 1159-66.
70. Kuramitsu H, Tokuda M, Yoneda M, Duncan M, Cho MI. Multiple colonization defects in a cysteine protease mutant of Porphyromonas gingivalis. J Periodontal Res 1997; 32: 140-2.
71. Yoneda M, Hirofuji T, Motooka N, Anan H, Hamachi T, Miura M, et al. Antibody responses to Porphyromonas gingivalis infection in a murine abscess model - involvement of gingipains and responses to re-infection. J Periodontal Res 2003; 38: 551-6.
72. Kuramitsu HK. Proteases of Porphyromonas gingivalis: what don't they do? Oral Microbiol Immunol 1998; 13: 263-70.
73. Shi Y, Ratnayake DB, Okamoto K, Abe N, Yamamoto K, Nakayama K. Genetic analyses of proteolysis, hemoglobin binding, and hemagglutination of Porphyromonas gingivalis. Construction of mutants with a combination of rgpA, rgpB, kgp, and hagA. J Biol Chem 1999; 274: 17955-60.
74. McKee AS, McDermid AS, Baskerville A, Dowsett AB, Ellwood DC, Marsh PD. Effect of hemin on the physiology and virulence of Bacteroides gingivalis W50. Infect Immun 1986; 52: 349-55.
75. Genco CA, Odusanya BM, Potempa J, Mikolajczyk-Pawlinska J, Travis J. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Infect Immun 1998; 66: 4108-14.
76. O'Brien-Simpson NM, Paolini RA, Reynolds EC. RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model. Infect Immun 2000; 68: 4055-63.
77. Beveridge TJ, Makin SA, Kadurugamuwa JL, Li Z. Interactions between biofilms and the environment. FEMS Microbiol Rev 1997; 20: 291-303.
78. Amano A. Disruption of epithelial barrier and impairment of cellular function by Porphyromonas gingivalis. Front Biosci 2007; 12: 3965-74.
79. Isogai H, Isogai E, Yoshimura F, Suzuki T, Kagota W, Takano K. Specific inhibition of adherence of an oral strain of Bacteroides gingivalis 381 to epithelial cells by monoclonal antibodies against the bacterial fimbriae. Arch Oral Biol 1988; 33: 479-85.
80. Weinberg A, Belton CM, Park Y, Lamont RJ. Role of fimbriae in Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun 1997; 65: 313-6.
81. Njoroge T, Genco RJ, Sojar HT, Hamada N, Genco CA. A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect Immun 1997; 65: 1980-4.
82. Amano A, Nakagawa I, Okahashi N, Hamada N. Variations of Porphyromonas gingivalis fimbriae in relation to microbial pathogenesis. J Periodontal Res 2004; 39: 136-42.
83. Lamont RJ, Yilmaz O. In or out: the invasiveness of oral bacteria. Periodontol 2000 2002; 30: 61-9.
84. Hamada S, Fujiwara T, Morishima S, Takahashi I, Nakagawa I, Kimura S, et al. Molecular and immunological characterization of the fimbriae of Porphyromonas gingivalis. Microbiol Immunol 1994; 38: 921-30.
85. Nakagawa I, Amano A, Kimura RK, Nakamura T, Kawabata S, Hamada S. Distribution and molecular characterization of Porphyromonas gingivalis carrying a new type of fimA gene. J Clin Microbiol 2000; 38: 1909-14.
86. Nakagawa I, Amano A, Ohara-Nemoto Y, Endoh N, Morisaki I, Kimura S, et al. Identification of a new variant of fimA gene of Porphyromonas gingivalis and its distribution in adults and disabled populations with periodontitis. J Periodontal Res 2002; 37: 425-32.
87. Bodet C, Chandad F, Grenier D. Porphyromonas gingivalisinduced inflammatory mediator profile in an ex vivo human whole blood model. Clin Exp Immunol 2006; 143: 50-7.
88. Perez-Chaparro PJ, Lafaurie GI, Gracieux P, Meuric V, Tamanai-Shacoori Z, Castellanos JE, et al. Distribution of Porphyromonas gingivalis fimA genotypes in isolates from subgingival plaque and blood sample during bacteremia. Biomedica 2009; 29: 298-306.
89. Amano A, Kuboniwa M, Nakagawa I, Akiyama S, Morisaki I, Hamada S. Prevalence of specific genotypes of Porphyromonas gingivalis fimA and periodontal health status. J Dent Res 2000; 79: 1664-8.
90. Eick S, Rodel J, Einax JW, Pfister W. Interaction of Porphyromonas gingivalis with KB cells: comparison of different clinical isolates. Oral Microbiol Immunol 2002; 17: 201-8.
91. Amano A, Nakagawa I, Kataoka K, Morisaki I, Hamada S. Distribution of Porphyromonas gingivalis strains with fimA genotypes in periodontitis patients. J Clin Microbiol 1999; 37: 1426-30.
92. Nakano K, KuboniwaM, Nakagawa I, Yamamura T, Nomura R, Okahashi N, et al. Comparison of inflammatory changes caused by Porphyromonas gingivalis with distinct fimA genotypes in a mouse abscess model. Oral Microbiol Immunol 2004; 19: 205-9.
93. Narayanan SK, Nagaraja TG, Chengappa MM, Stewart GC. Leukotoxins of Gram-negative bacteria. Vet Microbiol 2002; 84: 337-56.
94. Johansson A, Claesson R, Hanstrom L, Sandstrom G, Kalfas S. Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans. J Periodontal Res 2000; 35: 85-92.
95. Mangan DF, Taichman NS, Lally ET, Wahl SM. Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun 1991; 59: 3267-72.
96. Pucar A, Milasin J, Lekovic V, Vukadinovic M, Ristic M, Putnik S, et al. Correlation between atherosclerosis and periodontal putative pathogenic bacterial infections in coronary and internal mammary arteries. J Periodontol 2007; 78: 677-82.
97. Campbell JH, Campbell GR. The cell biology of atherosclerosis - new developments. Aust NZ J Med 1997; 27: 497-500.
98. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
99. Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol 2006; 1: 297-329.
100. Jawien J. New insights into immunological aspects of atherosclerosis. Pol Arch Med Wewn 2008; 118: 127-31.
101. Nanci A, Bosshardt DD. Structure of periodontal tissues in health and disease. Periodontol 2000 2006; 40: 11-28.
102. Parahitiyawa NB, Jin LJ, Leung WK, Yam WC, Samaranayake LP. Microbiology of odontogenic bacteremia: beyond endocarditis. Clin Microbiol Rev 2009; 22: 46-64.
103. Kinane DF, Riggio MP, Walker KF, MacKenzie D, Shearer B. Bacteraemia following periodontal procedures. J Clin Periodontol 2005; 32: 708-13.
104. Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteraemia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 2006; 33: 401-7.
105. Crasta K, Daly CG, Mitchell D, Curtis B, Stewart D, Heitz-Mayfield LJA. Bacteraemia due to dental flossing. J Clin Periodontol 2009; 36: 323-32.
106. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000; 71: 1554-60.
107. Kozarov VI, Dorn BR, Shelburne CE, DunnWA Jr, Progulske-Fox A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porpyromonas gingivalis. Arterioscler Thromb Vasc Biol 2005; 25: e17-8.
108. Elkaim R, Dahan M, Kocgozlu L, Werner S, Kanter D, Kretz JG, et al. The prevalence of periodontal pathogens in subgingival lesions, atherosclerotic plaques, and healthy blood vessels: a preliminary study. J Periodont Res 2008; 43: 224-31.
109. Ford PJ, Gemmell E, Hamlet SM, Hasan A, Walker PJ, West MJ, et al. Cross-reactivity of GroEL antibodies with human heat shock protein 60 and quantification of pathogens in atherosclerosis. Oral Microbiol Immunol 2005; 20: 296-302.
110. Ford PJ, Gemmell E, Chan A, Carter CL, Walker PJ, Bird PS, et al. Inflammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study. Oral Microbiol Immunol 2006; 21: 206-11.
111. Nakano K, Nemoto H, Nomura R, Inaba H, Yoshioka H, Taniguchi K, et al. Detection of oral bacteria in cardiovascular specimens. Oral Microbiol Immunol 2009; 24: 64-8.
112. Gaetti-Jardim E Jr, Marcelino SL, Feitosa AC, Romito GA, Avila-Campos MJ. Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. J Med Microbiol 2009; 58: 1568-75.
113. Giacona MB, Papapanou PN, Lamster IB, Rong LL, D'Agati VD, Schmidt AM. Porphyromonas gingivalis induces its uptake by human macrophages and promotes foam cell formation in vitro. FEMS Microbiol Lett 2004; 241: 95-101.
114. Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 1998; 66: 5337-43.
115. Dorn BR, Dunn WA Jr, Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens. Infect Immun 1999; 67: 5792-8.
116. Abranches J, Zeng L, Belanger M, Rodrigues PH, Simpson-Haidaris PJ, Akin D, et al. Invasion of human coronary artery endothelial cells by Streptococcus mutans OMZ175. Oral Microbiol Immunol 2009; 24: 141-5.
117. Dorn BR, Dunn WA Jr, Progulske-Fox A. Porphyromonas gingivalis traffics to autophagosomes in human coronary artery endothelial cells. Infect Immun 2001; 69: 5698-708.
118. Roth GA, Moser B, Huang SJ, Brandt JS, Huang Y, Papapanou PN, et al. Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. J Thromb Haemost 2006; 4: 2256-61.
119. Roth GA, Moser B, Roth-Walter F, Giacona MB, Harja E, Papapanou PN, et al. Infection with periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells. Atherosclerosis 2007; 190: 271-81.
120. Roth GA, Ankersmit HJ, Brown VB, Papapanou PN, Schmidt AM, Lalla E. Porphyromonas gingivalis infection and cell death in human aortic endothelial cells. FEMS Microbiol Lett 2007; 272: 106-13.
121. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol 2004; 25: 489-95.
122. Kerrigan SW, Jakubovics NS, Keane C, Maguire P, Wynne K, Jenkinson HF, et al. Role of Streptococcus gordonii surface proteins SspA/SspB and Hsa in platelet function. Infect Immun 2007; 75: 5740-7.
123. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 2006; 4: 445-57.
124. Kerrigan SW, Cox D. Platelet-bacterial interactions. Cell Mol Life Sci 2010; 67: 513-23.
125. Erickson PR, HerzbergMC. The Streptococcus sanguis platelet aggregation-associated protein. J Biol Chem 1993; 268: 1646-9.
126. Plummer C, Wu H, Kerrigan SW, Meade G, Cox D, Douglas CWI. A serine-rich glycoprotein of Streptococcus sanguis mediates adhesion to platelets via GPIb. Br J Haematol 2005; 129: 101-9.
127. Takahashi Y, Ruhl S, Yoon JW, Sandberg AL, Cisar JO. Adhesion of biridans group streptococci to sialic acid-, galactose-, and N-acetylgalactosamine-containing receptors. Oral Microbiol Immunol 2002; 17: 257-62.
128. Taniguchi N, Nakano K, Nomura R, Naka S, Kojima A, Matsumoto M, et al. Defect of glucosyltransferases reduces platelet aggregation activity of Streptococcus mutans: analysis of clinical strains isolated from oral cavities. Arch Oral Biol 2010; 55: 410-6.
129. Sharma A, Novak EK, Sojar HT, Swank RT, Kuramitsu HK, Genco RJ. Porphyromonas gingivalis platelet aggregation activity: outer membrane vesicles are potent activators of murine platelets. Oral Microbiol Immunol 2000; 15: 393-6.
130. Herzberg MC, MacFarlane GD, Liu P, Erickson PR. In: Molecular pathogenesis of periodontal diseases. Washington, DC: ASM Press; 1994.
131. Holt SC, Bramanti TE. Factors in virulence expression and their role in periodontal disease pathogenesis. Crit Rev Oral Biol Med 1991; 2: 177-281.
132. Naito M, Sakai E, Shi Y, Ideguchi H, Shoji M, Ohara N, et al. Porphyromonas gingivalis-induced platelet aggregation in plasma depends on Hgp44 adhesion but not Rgp proteinase. Mol Microbiol 2006; 59: 152-67.
133. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
134. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149-53.
135. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767-72.
136. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-65.
137. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation 1997; 96: 4219-25.
138. Stoll LL, Denning GM, Weintraub NL. Potential role of edotoxin as a proinflammatory mediator in atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 2227-36.
139. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 2000; 79: 49-57.
140. Amar S, Gokce N, Morgan S, Loukideli M, Van Dyke TE, Vita JA. Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol 2003; 23: 1245-9.
141. Ebersole JE, Machen RL, Steffen MJ, Willmann DE. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 1997; 107: 347-52.
142. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001; 72: 1221-7.
143. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000; 71: 1528-34.
144. Nakajima T, Honda T, Domon H, Okui T, Kajita K, Ito H et al. Periodontitis-associated up-regulation of systemic inflammatory mediator level may increase the risk of coronary heart disease. J Periodontal Res 2010; 45: 116-22.
145. Nibali L, D'Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol 2007; 34: 931-7.
146. Ide M, Jagadev D, Coward PY, Crook M, Barclay GR, Wilson RF. The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-6. J Periodontol 2004; 75: 420-8.
147. D'Auito F, Parkar M, Tonetti MS. Acute effects of periodontal therapy on bio-markers of vascular health. J Clin Periodontol 2007; 34: 124-9.
148. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007; 356: 911-20.
149. Elter JR, Hinderliter AL, Offenbacher S, Beck JD, Caughey M, Brodala N, et al. The effects of periodontal therapy on vascular endothelial function: a pilot trial. Am Heart J 2006; 151: e1-e47.
150. Yamazaki K, Honda T, Oda T, Ueki-Maruyama K, Nakajima T, Yoshie H, et al. Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res 2005; 40: 53-8.
151. Buhlin K, Hultin M, Norderyd O, Persson L, Pockley AG, Pussinen PJ, et al. Periodontal treatment influences risk markers for atherosclerosis in patients with severe periodontitis. Atherosclerosis 2009; 206: 518-22.
152. D'Auito F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti M. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomised controlled clinical trial. Am Heart J 2006; 151: 977-84.
153. Vidal F, Figueredo CM, Cordovil I, Fischer RG. Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol 2009; 80: 786-91.
154. Hussain Bokhari SA, Khan AA, Tatakis DN, Azhar M, Hanif M, Izhar M. Non-surgical periodontal therapy lowers serum inflammatory markers: a pilot study. J Periodontol 2009; 80: 1574-80.
155. Behle JH, Sedaghatfar MH, Demmer RT, Wolf DL, Celenti R, Kebschull M, et al. Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol 2009; 36: 287-94.
156. D'Aiuto F, Parkar M, Brett PM, Ready D, Tonetti MS. Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections. Cytokine 2004; 28: 29-34.
157. Means RT. Hepcidin and cytokines in anaemia. Hematology 2004; 9: 357-62.
158. Hutter JW, van der Velden U, Varoufaki A, Huffels RA, Hoek FJ, Loos BG. Lower numbers of erythrocytes and lower levels of hemoglobin in periodontitis patients compared to control subjects. J Clin Periodontol 2001; 28: 930-6.
159. Pradeep AR, Sharma A, Arjun Raju P. Anemia of chronic disease and chronic periodontitis: does periodontal therapy have effect on anemic status. J Periodontol 2010: aheadofprint.
160. Taylor B, Tofler G, Morel-Kopp MC, Carey H, Carter T, Elliott M, et al. The effect of initial treatment of periodontitis on systemic markers of inflammation and cardiovascular risk: a randomized controlled trial. Eur J Oral Sci 2010; 118: 350-6.
161. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008; 35: 277-90.
162. Wick G, Perschinka H, Xu Q. Autoimmunity and atherosclerosis. Am Heart J 1999; 138: s444-9.
163. Polla BS. A role for heat shock proteins in inflammation? Immunol Today 1988; 9: 134-7.
164. Fink AL. Chaperone-mediated protein folding. Physiol Rev 1999; 79: 425-9.
165. Kauffman S. Heat shock proteins and the immune response. Immunol Today 1990; 11: 129-36.
166. Perschinka H, Mayr M, Millonig G, Mayerl C, van der Zee R, Morrison SG, et al. Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol 2003; 23: 1060-5.
167. Zhu J, Quyyumi AA, Rott D, Csako G, Wu H, Halcox J, et al. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease. Circulation 2001; 103: 1071-5.
168. Metzler B, Schett G, Kleindienst R, van der Zee R, Ottenhoff T, Hajeer A, et al. Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 536-41.
169. Mayr M, Metzler B, Kiechl S, Willeit J, Schett G, Xu Q, et al. Endothelial cytotoxicity mediated by serum antibodies to heatshock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat-shock proteins as a possible link between infection and atherosclerosis. Circulation 1999; 99: 1560-6.
170. Ellins E, Shamaei-Tousi A, Steptoe A, Donald A, O'Meagher S, Halcox J, et al. The relationship between carotid stiffness and circulation levels of heat shock protein 60 in middle-aged men and women. J Hypertens 2008; 26: 2389-92.
171. Pockley AG, Wu R, Lemne C, Kiessling R, de Faire U, Frostegard J. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 2000; 36: 303-7.
172. Xu Q, Wick G. The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today 1996; 2: 372-9.
173. Welch WJ. Heat shock proteins functioning as molecular chaperones: their roles in normal and stressed cells. Phil Trans R Soc Lond B Biol Sci 1993; 339: 327-33.
174. Goulhen F, Grenier D, Mayrand D. Oral microbial heat-shock proteins and their potential contributions to infections. Crit Rev Oral Biol Med 2003; 14: 399-412.
175. Maeda H, Miyamoto M, Hongyo H, Nagai A, Kurihara H, Muryama Y. Heat shock protein 60 (GroEL) from Porphyromonas gingivalis: molecular cloning and sequence analysis of its gene and purification of the recombinant protein. FEMS Microbiol Lett 1994; 119: 129-35.
176. Tabeta K, Yamazaki K, Hotokezaka H, Yoshie H, Hara K. Elevated humoral immune response to heat shock protein 60 (hsp60) family in periodontitis patients. Clin Exp Immunol 2000; 120: 285-93.
177. Yamazaki K, Ohsawa Y, Tabeta K, Ito H, Ueki K, Oda T, et al. Accumulation of human heat shock protein 60-reactive T cells in the gingival tissues of periodontitis patients. Infect Immun 2002; 70: 2492-501.
178. Ford P, Gemmell E, Walker P, West M, Cullinan M, Seymour G. Characterisation of heat shock protein-specific T cells in atherosclerosis. Clin Diagn Lab Immunol 2005; 12: 259-67.
179. Yamazaki K, Ueki-Maruayama K, Honda T, Nakajima T, Seymour GJ. Effect of periodontal treatment on the serum antibody levels to heat shock proteins. Clin Exp Immunol 2004; 135: 478-82.
180. George J, Shoenfeld Y, Afek A, Gilburd B, Keren P, Shaish A, et al. Enhanced fatty streak formation in C57BL/6 mice by immunisation with heat shock protein-65. Arterioscler Thromb Vasc Biol 1999; 19: 505-10.
181. Foteinos G, Afzal AR, Mandal K, Jahangiri M, Xu Q. Antiheat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage. Circulation 2005; 112: 1206-13.
182. van Puijvelde GHM, van Es T, van Wanrooij EJA, Habets KLL, deVos P, van der Zee R, et al. Induction of oral tolerance to HSP60 or and HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 2677-83.
183. Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, et al. The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol 2009; 80: 1021-32.